A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults.
Tiono AB, Plieskatt JL, Ouedraogo A, Soulama BI, Miura K, Bougouma EC, Naghizadeh M, Barry A, Yaro JBB, Ezinmegnon S, Henry N, Ofori EA, Adu B, Singh SK, Konkobo A, Lövgren Bengtsson K, Diarra A, Carnrot C, Reimer JM, Ouedraogo A, Tienta M, Long CA, Ouedraogo IN, Sagara I, Sirima SB, Theisen M.
Tiono AB, et al. Among authors: plieskatt jl.
J Clin Invest. 2024 Apr 1;134(7):e175707. doi: 10.1172/JCI175707.
J Clin Invest. 2024.
PMID: 38290009
Free PMC article.
Clinical Trial.